- $1.33bn
- $2.72bn
- $588.90m
Teva rises as FDA accepts to review biosimilar to eye disease drug Eylea
Brief: Alvotech And Teva Announce Filing Acceptance Of U.S. Biologics License Application
Brief: Alvotech And Teva Announce Filing Acceptance Of U.S. Biologics License Application
UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year
Brief: MedImpact Expands Access To Two Humira Biosimilars For New Patients
Cigna to remove AbbVie's Humira from some drug reimbursement lists next year
Alvotech rises on higher Q1 revenue
U.S. STOCKS ON THE MOVE-ProShares Ether, International Business Machines, Alvotech
Alvotech rises on deal with Dr Reddy's on biosimilar to Amgen's bone drugs
Brief: Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK
Brief: Alvotech Says It Will Manufacture Its High-Concentration Interchangeable Biosimilar To Humira For Quallent Pharmaceuticals
Brief: Alvotech Signs U.S. Agreement To Expand Access For Newly Approved High-Concentration Interchangeable Biosimilar To Humira® (adalimumab)
Teva, Alvotech rise as FDA approves Stelara biosimilar
Brief: Alvotech And Teva Announce U.S. FDA Approval Of SELARSDI(Ustekinumab-Aekn), Biosimilar To Stelara (Ustekinumab)
Brief: Alvotech And Teva Announce U.S. FDA Approval Of Selarsdi™ (Ustekinumab-Aekn), Biosimilar To Stelara® (Ustekinumab)
Teva's US-listed shares up as FDA approves Humira biosimilar
Brief: Alvotech And Teva Announce U.S. Approval Of Simlandi Injection
U.S. STOCKS ON THE MOVE-Super Micro, Albemarle
U.S. STOCKS ON THE MOVE-Ginkgo, Jfrog, Alvotech